Guardant Health, Inc. (GH) stock
GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$154.86+0.08 (+0.05%)
Close on Nov 12, 2026Market cap $20.78BP/E –Yield –
Guardant Health enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Guardant Health's enterprise value was $19.63B on Nov 11, 2026, against $12.97B a year earlier. Over the last 5 years it ranged from $1.02B to $22.84B, with a median of $4.32B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $19.63B | +61.0% |
| 2025 | Dec 31, 2025 | $12.19B | +325.2% |
| 2024 | Dec 31, 2024 | $2.87B | +41.0% |
| 2023 | Dec 29, 2023 | $2.03B | +11.2% |
| 2022 | Dec 30, 2022 | $1.83B | -78.9% |
| 2021 | Dec 31, 2021 | $8.68B | -26.8% |
| 2020 | Dec 31, 2020 | $11.86B | +74.2% |
| 2019 | Dec 31, 2019 | $6.81B | +3038.4% |
| 2018 | Dec 31, 2018 | $217.01M | – |
See a number that looks wrong?